Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Delsys to develop oral formulations of Parke-Davis drugs

May 4, 1998

Progenitor receives patent protection for stem cell technology

May 4, 1998

NeoRx receives SBIR grant for development of Pretarget technology

May 4, 1998

Improved gastrointestinal delivery of heparin with SNAC

May 1, 1998

Genetronics begins phase II trial of electroporation therapy in U.S.

May 1, 1998

CV Technologies reveals ChemBioPrint technology

April 29, 1998

Xoma licenses protein production technology to Invitrogen for research use

April 29, 1998

Abgenix, Genentech form research collaboration

April 29, 1998

Theratechnologies and Genetix enter strategic alliance

April 28, 1998

Genometrix and GeneMedicine embark on high-throughput screening effort

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...